Del. Justices Reject Third Chance For BioScrip Investors

Delaware's Supreme Court on Monday shot down a class attempt to resurrect an already-recycled suit against directors of home infusion and pharmacy service company BioScrip Inc., prompted by insider trading and...

Already a subscriber? Click here to view full article